How's that approval going in the States?
Regulators, doctors & parameds tend to take note when the FDA delays or doesn't approve something. Their concern is genuine & founded in fact. I still believe it will achieve approval, but the spotlight on the safety issues will not go un-noticed.
Within a strict set of parameters methoxy works & works well.
Take his opinion with a grain of salt, a good investor would. Flip side is, I've been asking here for weeks who methoxy's competitors are & no one here could tell me. Now I know and Ketamine looks to be an extremely versatile, low risk analgesic. Tough competition to knock off.
He also pointed me to a study done by a colleague on using Sevoflourane in a green whistle. I'll post details soon.
I believe there are years of growth ahead for methoxy sales, I'm just not convinced its the blockbuster some believe it to be.
How's that approval going in the States? Regulators, doctors &...
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
41.5¢ |
Change
0.005(1.22%) |
Mkt cap ! $35.81M | |||
| Open | High | Low | Value | Volume |
| 41.3¢ | 42.5¢ | 41.3¢ | $48.32K | 115.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1126 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.5¢ | 23636 | 2 |
View Market Depth
| Last trade - 15.44pm 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
41.8¢ |
Change
0.005 ( 1.11 %) |
||||
| Open | High | Low | Volume | ||
| 42.0¢ | 42.5¢ | 41.5¢ | 20285 | ||
| Last updated 15.32pm 04/06/2024 ? | |||||
| MVP (ASX) Chart |